Skip to main content
. Author manuscript; available in PMC: 2018 Jun 19.
Published in final edited form as: Psychoneuroendocrinology. 2015 Dec 30;66:22–30. doi: 10.1016/j.psyneuen.2015.12.027

Table 2.

Effects of OXT treatment and partner presence or absence on anxiety-like behavior and agonistic behavior.

Behavior Pro8-OXT Leu8-OXT Saline OXTA F value p value Partner absent Partner present F value p value
Anxiety-like behavior
Scratchinga 6.0 (1.8) 5.0 (1.0) 6.0 (2.4) 4.0 (1.2) 0.57 0.64 4.4 (1.0) 6.2 (1.6) 1.59 0.24
Locomotionb 2.5 (0.5) 2.4 (0.5) 3.1 (0.7) 2.6 (0.7) 0.84 0.49 2.7 (0.7) 2.6 (0.5) 0.02 0.90
Agonistic behavior
Phee calla 8.4 (4.0) 10.8 (3.2) 9.2 (4.0) 12.4 (5.2) 0.35 0.80 16.0 (5.6) 4.2 (2.0) 4.80 0.06
Scent markinga 5.4 (2.4) 2.8 (1.2) 1.8 (1.0) 2.8 (1.6) 1.06 0.39 2.0 (1.2) 4.4 (1.6) 1.47 0.26
Enclosure manipulationa 1.4 (0.8) 1.4 (1.0) 3.0 (1.8) 1.2 (0.4) 0.68 0.57 2.4 (1.2) 1.0 (0.4) 1.14 0.32

Data are expressed as a function of OXT treatment and partner presence or absence during the stressor. N = 10.

a

The mean (±SEM) frequency (per hour of observation).

b

The mean (±SEM) duration (minutes per hour of observation) of each behavior.